Form 8-K - Current report:
SEC Accession No. 0001193125-11-099845
Filing Date
2011-04-18
Accepted
2011-04-15 18:34:18
Documents
3
Period of Report
2011-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d8k.htm 8-K 18119
2 PRESS RELEASE dex991.htm EX-99.1 7856
3 GRAPHIC g175254g13q33.jpg GRAPHIC 3443
  Complete submission text file 0001193125-11-099845.txt   32182
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 11764064
SIC: 2835 In Vitro & In Vivo Diagnostic Substances